Bvf Has Trimmed Holding in Chemocentryx (CCXI) by $67.90 Million as Market Value Rose; Autonomy Capital LP Increases Holding in Irsa Inversiones Y Rep S A (IRS)

IRSA Inversiones y Representaciones Sociedad Anónima (NYSE:IRS) Logo

Autonomy Capital Lp increased its stake in Irsa Inversiones Y Rep S A (IRS) by 1.74% based on its latest 2019Q1 regulatory filing with the SEC. Autonomy Capital Lp bought 50,000 shares as the company’s stock declined 38.33% while stock markets rallied. The hedge fund held 2.92 million shares of the homebuilding company at the end of 2019Q1, valued at $31.80M, up from 2.87M at the end of the previous reported quarter. Autonomy Capital Lp who had been investing in Irsa Inversiones Y Rep S A for a number of months, seems to be bullish on the $589.07 million market cap company. The stock increased 1.50% or $0.15 during the last trading session, reaching $10.12. About 272,709 shares traded or 188.27% up from the average. IRSA Inversiones y Representaciones Sociedad Anónima (NYSE:IRS) has declined 54.15% since July 7, 2018 and is downtrending. It has underperformed by 58.58% the S&P500. Some Historical IRS News: 10/05/2018 – IRSA 9M NET INCOME ARS11.29B; 15/05/2018 – Capital TV: #BREAKING: The water shortage in the country rises from 31% to 42%, reveals Irsa advisory committee during its meet; 12/03/2018 Research Report Identifies Essent Group, BanColombia S.A, Aegon NV, Delphi Technologies, IRSA Inversiones Y Representaciones S

Bvf Inc decreased its stake in Chemocentryx Inc (CCXI) by 78.1% based on its latest 2019Q1 regulatory filing with the SEC. Bvf Inc sold 5.22 million shares as the company’s stock rose 15.42% with the market. The hedge fund held 1.46 million shares of the health care company at the end of 2019Q1, valued at $20.34M, down from 6.69M at the end of the previous reported quarter. Bvf Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $516.05M market cap company. It closed at $8.89 lastly. It is down 11.16% since July 7, 2018 and is uptrending. It has outperformed by 6.73% the S&P500. Some Historical CCXI News: 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS); 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/03/2018 ChemoCentryx 4Q EPS 80c; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13

Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on August, 8. They expect $-0.21 EPS, down 50.00% or $0.07 from last year’s $-0.14 per share. After $-0.23 actual EPS reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts -8.70% EPS growth.

Investors sentiment increased to 1.44 in 2019 Q1. Its up 0.51, from 0.93 in 2018Q4. It increased, as 12 investors sold CCXI shares while 27 reduced holdings. 22 funds opened positions while 34 raised stakes. 33.34 million shares or 22.88% more from 27.13 million shares in 2018Q4 were reported. Sg Americas Ltd Liability Com stated it has 20,240 shares or 0% of all its holdings. American Int Gru holds 14,327 shares or 0% of its portfolio. Metropolitan Life Insurance New York holds 0.01% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI) for 42,380 shares. Citadel Advsrs Llc reported 26,133 shares. 148,988 are owned by Invesco Limited. D E Shaw & has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). Bank & Trust Of America Corp De holds 92,817 shares or 0% of its portfolio. Alliancebernstein Ltd Partnership accumulated 46,500 shares or 0% of the stock. Rhumbline Advisers has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). California State Teachers Retirement System holds 0% or 35,245 shares. Aqr Capital Mgmt Ltd Co has 22,364 shares for 0% of their portfolio. Fosun Int Ltd stated it has 0.08% in ChemoCentryx, Inc. (NASDAQ:CCXI). Charles Schwab Mngmt has invested 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). 49,812 are owned by Millennium Mgmt Limited Liability Co. Credit Suisse Ag has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI).

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Nasdaq.com which released: “Takeover of little-known Baoshang casts doubt over other small Chinese banks – Nasdaq” on May 30, 2019, also Seekingalpha.com with their article: “ChemoCentryx Looks Like An Attractive Investment – ChemoCentryx, Inc. (NASDAQ:CCXI) – Seeking Alpha” published on November 22, 2017, Seekingalpha.com published: “ChemoCentryx, Inc. (CCXI) CEO Thomas Schall on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” on March 12, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Nasdaq.com and their article: “ChemoCentryx (CCXI) Shares March Higher, Can It Continue? – Nasdaq” published on December 02, 2015 as well as Seekingalpha.com‘s news article titled: “InflaRx Tanks 91.79% As IFX-1 Phase II Trial Flops, Provides Bargain Buy For Competitor ChemoCentryx – Seeking Alpha” with publication date: June 08, 2019.

Bvf Inc, which manages about $999.89M and $893.07 million US Long portfolio, upped its stake in Arcus Biosciences Inc by 398,600 shares to 2.81 million shares, valued at $35.10 million in 2019Q1, according to the filing. It also increased its holding in Vical Inc by 993,211 shares in the quarter, for a total of 2.28 million shares, and has risen its stake in Alpine Immune Sciences Inc.

Since January 7, 2019, it had 0 buys, and 3 sales for $978,918 activity. $74,079 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) was sold by Cappel Markus J.. 37,893 ChemoCentryx, Inc. (NASDAQ:CCXI) shares with value of $457,747 were sold by KANAYA SUSAN M.

More notable recent IRSA Inversiones y Representaciones Sociedad Anónima (NYSE:IRS) news were published by: Finance.Yahoo.com which released: “Investors Who Bought Lennar (NYSE:LEN) Shares Five Years Ago Are Now Up 39% – Yahoo Finance” on May 04, 2019, also Finance.Yahoo.com with their article: “What You Must Know About Rogers Corporation’s (NYSE:ROG) Financial Health – Yahoo Finance” published on June 04, 2019, Finance.Yahoo.com published: “Fixing the IRS Means Spending Money to Save Money – Yahoo News” on April 15, 2019. More interesting news about IRSA Inversiones y Representaciones Sociedad Anónima (NYSE:IRS) were released by: Prnewswire.com and their article: “IRSA Inversiones y Representaciones SA announces Results for the FY 2018 Ended June 30, 2018 – PR Newswire” published on September 05, 2018 as well as Forbes.com‘s news article titled: “KAR Auctions Services Targets Spin Of Insurance Auto Auctions Spinco In 2Q – Forbes” with publication date: April 23, 2019.

ChemoCentryx, Inc. (NASDAQ:CCXI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *